Skip to main content
ASIX logo

ASIX · AdvanSix Inc.

Track ASIX — free
$15.10 -0.14 (-0.92%)
Ex-dividend: $0.16 · Nov 17, 2026 Return incl. dividend (before tax) +0.13%
Market Cap
$411.61M
Shares
27.01M
Volume · Nov 17 10.04K Avg daily vol (3M) 277.25K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$15.24 Open$15.56 Day$15.23–15.70 52W close$14.30–26.17 Avg vol 30d277K Short int528K · 2.0% of shares · 2.2d Short vol38% Last earningsNov 4, 2026 DataJan 2020–Nov 2026 Filing10-Q · Nov 4

Up next

Feb 19, 2027 Est · unconfirmed · in 13 wks

Latest documents

2026
Nov 4
Earnings call
Sales rise 15%; $47 million USDA funding proposed

AdvanSix reported 15% sales growth to $431 million and $30 million of free cash flow, while adjusted EBITDA fell to $15 million; Project Century was selected for $47 million in proposed USDA funding and is expected to add approximately 84,000 tons of annual ammonia production.

5 source passages
Sales increased 15% year-over-year to $431 million, driven by 17% favorable pricing, partially offset by a 2% decline in volume. Adjusted EBITDA was $15 million, down $10 million from last year. CapEx declined by $8 million to $18 million as planned, supporting $30 million of free cash flow generation in the quarter. ADVANCEX was selected to receive $47 million in proposed funding through the USDA Fields Program. The project is expected to add approximately 84,000 tons of annual ammonia production, while also improving reliability, enhancing logistics infrastructure, and advancing the modernization of our operations through upgraded controls and digital optimization tools. Open the document at this passage
Nov 4
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Sales rise approximately 8%, but nine-month loss reaches $19.9 million

For the nine months ended September 30, 2026, AdvanSix reported sales up approximately 8%, but a net loss of $19.9 million. Third-quarter sales increased approximately 15%.

Revenue $430.81M ▲ 15.0% Net loss $7.56M Diluted EPS -$0.28
Read from the MD&A section
4 source passages
AdvanSix is a vertically integrated chemistry company that produces essential materials for diverse end markets. Sales increased in the nine months ended September 30, 2026 compared to the prior year period by $94.0 million (approximately 8%) Net income (loss) was ($7.6) million and ($19.9) million for the three and nine months ended September 30, 2026, respectively Sales increased in the three months ended September 30, 2026 compared to the prior year period by $56.3 million (approximately 15%) Open the document at this passage
Nov 4
Current report 8-K
Third-quarter sales rise 15% as adjusted EPS turns negative

AdvanSix reported third-quarter 2026 sales of $431 million, up 15%, diluted EPS of ($0.28), adjusted EPS of ($0.24), and operating cash flow of $48 million, up $21 million; the Board declared a $0.16 per-share dividend payable December 1, 2026.

Financial results, Other events
5 source passages
3Q26 Sales of $431 million, up 15% versus prior year 3Q26 Earnings Per Share of ($0.28); Adjusted Earnings Per Share of ($0.24) 3Q26 Cash Flow from Operations of $48 million, up $21 million versus prior year AdvanSix Inc. The Company's Board of Directors declared a quarterly cash dividend of $0.16 per share on the Company's common stock. The dividend is payable on December 1, 2026 to stockholders of record as of the close of business on November 17, 2026. Open the document at this passage
Aug 7
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $421.28M ▲ 2.7% Net income $3.25M ▼ 89.6% Diluted EPS $0.12 ▼ 89.6%
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.62B
Trailing 12 months
Net income (TTM)
−$22.64M
Trailing 12 months
Revenue growth YoY
+15.0%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
0.9%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$245.93M
Latest balance sheet
Dividend yield
4.2%
Trailing 12 months
Shares change YoY
+0.6%
Year over year · more shares
Price change (1Y)
-3.0%
Trailing year
Short interest
2.0%
Latest settlement · 2.2 days to cover
View all 125 metrics

AI Brief

Q2 FY26 earnings call · Aug 7, 2026
Q2 FY26

TL;DR. AdvanSix's Q2 results showed 3% sales growth to $421 million, but adjusted EPS fell 85% to $0.19 and adjusted EBITDA dropped 43% to $31.9 million on weaker plant nutrients volumes; management guided to second-half sequential improvement supported by lower CapEx, a $0.16 dividend, and progress on the DEF project and USDA FIELDS grant application for ammonia capacity expansion.

Bullish
  • + CapEx guidance of $75–$95 million in 2026, down from $116 million in 2025, supports second-half free cash flow improvement.
  • + Full-year 2026 ammonia sales volume expected up 30% versus the prior record year 2025.
  • + Targeting approximately $10 million savings exiting 2026 from the multi-year non-manpower fixed cost reduction program.
Bearish
  • − Q2 adjusted EPS of $0.19 was down 85% year-over-year and adjusted EBITDA fell 43% to $31.9 million on lower plant nutrients volumes.
  • − Plant Nutrients sales fell 16% year-over-year to $131.4 million as weaker farmer economics reduced in-season fertilizer purchases.
  • − Q2 2026 plant turnaround pre-tax impact of ~$10 million and full-year turnaround impact now expected at ~$17 million vs. previously expected to be lower.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 22.9 · elevated Equity put/call 0.73
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −22%
below
Price vs 50-day avg −5%
below
RSI (14) 43
neutral
MACD trend Positive
52-week position 8%
near low
Momentum
relative strength
Very Weak
1-month return −5%
trailing
6-month return −33%
trailing
YTD return −12%
this year
Relative strength −31%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $16 › 200d $19 — 200d above 50d
Institutional flow Distributing
-2% holders QoQ · +26 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
1.96% of shares out · ▼ -11.5% MoM · 2.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
254 holders — near 3-yr low, contrarian setup
Squeeze score 38
low risk · 0–100
Fundamentals
Strong
Revenue growth +45%
Y/Y
Gross margin 8%
contracting
EPS growth +11%
Y/Y
Free cash flow $6.4M
Buyback $62.0M
remaining
Balance sheet $195.2M
net debt
Quant / Vol
risk profile
Very High
Volatility 50%
annualized · 1-yr
Max drawdown −43%
past year
ATR 4.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Aug 7, 2026
exiting 2026
Multi-year non-manpower fixed cost reduction savings $10M
Savings from multi-year non-manpower fixed cost reduction progra $10M
full year 2026
Ammonia sales volume 30%
Previous outlook earlier release · from the Earnings Call filed May 8, 2026

Still-open targets the latest release did not restate under the same label.

Capex · full year $75M – $95M
Prior guidance period ended · from the Earnings Call filed Feb 20, 2026
Unfavorable earnings impact · first quarter $8M – $10M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 2 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−22% Bearish
Price vs 50-day avg
−5% Bearish
RSI (14)
43 Neutral
MACD trend
Positive Bullish
52-week position
8% Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $16 › 200d $19 — 200d above 50d
Institutional flow Distributing
-2% holders QoQ · +26 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
1.96% of shares out · ▼ -11.5% MoM · 2.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
254 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $14 Now $15 · 8% Range high $26
vs 200-day avg -22% vs 50-day avg -5%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted EBITDA (non-GAAP) non-GAAP $31.89M Three Months Ended June 30, 2026 filing —
Adjusted EBITDA Margin non-GAAP 4.4% Six Months Ended June 30 —
Adjusted EPS - Basic non-GAAP -$0.3 Six Months Ended June 30 —
Adjusted EPS - Diluted non-GAAP -$0.3 Six Months Ended June 30 —
Adjusted Net income (loss) (non-GAAP) non-GAAP $5.2M Three Months Ended June 30, 2026 filing —
Total approximate dividend amount $4.3M three months ended June 30, 2026 filing —
Total dividend per share $0.16 three months ended June 30, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Chemicals — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ASIX
AdvanSix Inc.
this stock
$411.61M -11.9% +45.5% — 2.0%
SHECF
Shin-Etsu Chemical Co., Ltd.
$70.81B +10.7% — — 0.1%
DOW
Dow Inc.
$23.14B +36.7% -7.0% — 3.8%
CE
Celanese Corp
$5.37B +15.8% -7.1% 20.7 5.6%
MEOH
Methanex Corp
$5.17B +68.4% — — 3.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
254
% held
88.8%
Net QoQ
-908.2K sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
195
View
Short & Settlement
Short Interest Falling
Shares short
528.4K
Days to cover
2.2d
Change
-68.4K sh
View
Short Volume
Short vol %
38%
As of
Nov 16, 2026
Short Total
View
Fails to Deliver
FTD shares
1.5K
Value
$23.5K
As of
Oct 26, 2026
View
Off-Exchange
Off-exchange %
41.6%
Week of
Oct 12, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$1.7B
Net income (FY)
$49.3M
EPS diluted
$1.80
View
Buybacks
Authorized
$225.0M
Remaining
$62.0M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Nov 4, 2026
This year
14

AdvanSix reported third-quarter 2026 sales of $431 million, up 15%, diluted EPS of ($0.28), adjusted EPS of ($0.24), and operating cash flow of $48 million, up $21 million; the Board declared a $0.16 per-share dividend payable December 1, 2026.

View
Proposed Sales
Value
$42.8K
Shares
2.0K
Filed
Jun 10, 2026
View
Earnings & Events
Webcasts
Last webcast
Nov 4, 2026
View
Investor Relations
Latest news
ADVANSIX ANNOUNCES THIRD QUARTER…
Published
Nov 4, 2026
View

Performance

5D 20D 120D MTD YTD
ASIX -2.5% -5.1% -32.7% -0.8% -11.9%
SPY -1.7% -3.5% -1.4% -2.1% +8.5%
vs SPY -0.8% -1.6% -31.3% +1.3% -20.4%

Capital returns

Latest dividend
$0.16 / share · ex Nov 17, 2026
Raised 10.3%
Paid (TTM)
$0.80 / share · 5 payouts
Dividend yield (TTM, derived)
5.25%
Full dividend history
Buyback program · as of Sep 30, 2026
Authorized
$225.00M
Spent (derived)
$163.00M
Remaining
$62.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1673985 CUSIP 00773T101 13F (30d) 264 filings 224 filers Visit website Investor relations